Patient Surveillance After Cancer Treatment (Record no. 277042)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 09420nam a22006375i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-60327-969-7 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20160615110149.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 130321s2013 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781603279697 |
| -- | 978-1-60327-969-7 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-60327-969-7 |
| Source of number or code | doi |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | Alfaisal Main Library |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC254-282 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MJCL |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED062000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.994 |
| Edition number | 23 |
| 245 10 - TITLE STATEMENT | |
| Title | Patient Surveillance After Cancer Treatment |
| Medium | [electronic resource] / |
| Statement of responsibility, etc | edited by Frank E. Johnson, Yoshihiko Maehara, George P. Browman, Julie A. Margenthaler, Riccardo A. Audisio, John F. Thompson, David Y. Johnson, Craig C. Earle, Katherine S. Virgo. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS | |
| Place of production, publication, distribution, manufacture | Totowa, NJ : |
| Name of producer, publisher, distributor, manufacturer | Humana Press : |
| -- | Imprint: Humana Press, |
| Date of production, publication, distribution, manufacture | 2013. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XXI, 538 p. |
| Other physical details | online resource. |
| 336 ## - CONTENT TYPE | |
| Content Type Term | text |
| Content Type Code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media Type Term | computer |
| Media Type Code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier Type Term | online resource |
| Carrier Type Code | cr |
| Source | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 490 1# - SERIES STATEMENT | |
| Series statement | Current Clinical Oncology |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 1. Overview -- 2. Introduction to Cancer Surveillance Strategies -- 3. Using Decision Analysis to Model Cancer Surveillance -- 4. Cancer Survivorship: Monitoring the Long-Term and Late Effects of Treatment -- 5. Upper Aerodigestive Tract Carcinoma -- 6. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Europe -- 7. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Japan -- 8. Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint: Canada -- 9. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma -- 10. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma Surveillance Counterpoint: Australia -- 11. Thyroid (Papillary, Follicular, Medullary, Hürthle Cell) Carcinoma Surveillance Counterpoint: Japan -- 12. Lung Carcinoma -- 13. Lung Carcinoma Surveillance Counterpoint: Australia -- 14. Lung Carcinoma Surveillance Counterpoint: Japan -- 15. Lung Carcinoma Surveillance Counterpoint: Canada -- 16. Esophagus Carcinoma -- 17. Esophagus Carcinoma Surveillance Counterpoint: Australia -- 18. Esophagus Carcinoma Surveillance Counterpoint: Japan -- 19. Stomach -- 20. Stomach Carcinoma Surveillance Counterpoint: USA -- 21. Stomach Carcinoma Surveillance Counterpoint: Japan -- 22. Pancreatic Adenocarcinoma -- 23. Pancreatic Adenocarcinoma Surveillance Counterpoint: USA -- 24. Pancreatic Adenocarcinoma Surveillance Counterpoint: Europe -- 25. Pancreatic Adenocarcinoma Surveillance Counterpoint: Japan -- 26. Pancreatic Adenocarcinoma Surveillance Counterpoint: Canada -- 27. Liver and Biliary Tract Carcinoma -- 28. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Europe -- 29. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Australia -- 30. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Japan -- 31. Liver and Biliary Tract Carcinoma Surveillance Counterpoint: Canada -- 32. Colon and Rectum Carcinoma -- 33. Colon and Rectum Carcinoma Surveillance Counterpoint: USA -- 34. Colon and Rectum Carcinoma Surveillance Counterpoint: Australia -- 35. Colon and Rectum Carcinoma Surveillance Counterpoint: Japan -- 36. Colon and Rectum Carcinoma Surveillance Counterpoint: Canada -- 37. Anal Carcinoma -- 38. Anal Carcinoma Surveillance Counterpoint: USA -- 39. Anal Carcinoma Surveillance Counterpoint: Australia -- 40. Anal Carcinoma Surveillance Counterpoint: Japan -- 41. Anal Carcinoma Surveillance Counterpoint: Canada -- 42. Soft Tissue Sarcoma -- 43. Soft Tissue Sarcoma Surveillance Counterpoint: USA -- 44. Soft-Tissue Sarcoma Surveillance Counterpoint: Japan -- 45. Soft Tissue Sarcoma Surveillance Counterpoint: Canada -- 46. Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma -- 47. Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint: Japan -- 48. Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint: Canada -- 49. Cutaneous Melanoma -- 50. Cutaneous Melanoma Surveillance Counterpoint: USA -- 51. Cutaneous Melanoma Surveillance Counterpoint: Australia -- 52. Cutaneous Melanoma Surveillance Counterpoint: Japan -- 53. Breast Carcinoma -- 54. Breast Carcinoma Surveillance Counterpoint: USA -- 55. Breast Carcinoma Surveillance Counterpoint: Europe -- 56. Breast Carcinoma Surveillance Counterpoint: Australia -- 57. Breast Carcinoma Surveillance Counterpoint: Japan -- 58. Endometrial Carcinoma -- 59. Endometrial Cancer Surveillance Counterpoint: USA -- 60. Endometrial Cancer Surveillance Counterpoint: USA -- 61. Carcinoma of the Endometrium Surveillance Counterpoint: Japan -- 62. Endometrial Carcinoma Surveillance Counterpoint: Canada -- 63. Cervical Carcinoma -- 64. Cervical Carcinoma Surveillance Counterpoint: USA -- 65. Cervical Carcinoma Surveillance Counterpoint: Japan -- 66. Cervical Carcinoma Surveillance Counterpoint: Canada -- 67. Vaginal and Vulvar Carcinoma -- 68. Vaginal and Vulvar Carcinoma Surveillance Counterpoint: Japan -- 69. Ovarian Carcinoma -- 70. Ovarian Carcinoma Surveillance Counterpoint: USA -- 71. Ovarian Cancer Surveillance Counterpoint: Europe -- 72. Ovarian Cancer Surveillance Counterpoint: Japan -- 73. Renal Carcinoma -- 74. Renal Carcinoma Surveillance Counterpoint: Europe -- 75. Renal Carcinoma Surveillance Counterpoint: Japan -- 76. Renal Carcinoma Surveillance Counterpoint: Canada -- 77. Urinary Bladder Carcinoma -- 78. Urinary Bladder Carcinoma Surveillance Counterpoint: Japan -- 79. Urinary Bladder Carcinoma Surveillance Counterpoint: Canada -- 80. Prostate Carcinoma -- 81. Prostate Carcinoma Surveillance Counterpoint: USA -- 82. Prostate Carcinoma Surveillance Counterpoint: USA -- 83. Prostate Carcinoma Surveillance Counterpoint: Europe -- 84. Prostate Carcinoma Surveillance Counterpoint: Japan -- 85. Prostate Carcinoma Surveillance Counterpoint: Canada -- 86. Testicle Carcinoma -- 87. Testicle Carcinoma Surveillance Counterpoint: USA -- 88. Testicle Carcinoma Surveillance Counterpoint: Australia -- 89. Testicle Carcinoma Surveillance Counterpoint: Japan -- 90. Lymphoma -- 91. Lymphoma Surveillance Counterpoint: USA -- 92. Lymphoma Surveillance Counterpoint: Japan -- 93. Lymphoma (Following Autologous Stem Cell Transplant) -- 94. Lymphoma (Following Autologous Stem Cell Transplant) Surveillance Counterpoint: Japan -- 95. Leukemia -- 96. Leukemia Surveillance Counterpoint: USA -- 97. Leukemia Surveillance Counterpoint: Japan -- 98. Multiple Myeloma -- 99. Multiple Myeloma Surveillance Counterpoint: USA -- 100. Multiple Myeloma Surveillance Counterpoint: Australia -- 101. Multiple Myeloma Surveillance Counterpoint: Japan -- 102. Multiple Myeloma Surveillance Counterpoint: Canada -- 103. Glioma of the Central Nervous System -- 104. Glioma of the Central Nervous System Surveillance Counterpoint: Europe -- 105. Glioma of the Central Nervous System Surveillance Counterpoint: Australia -- 106. Glioma of the Central Nervous System Surveillance Counterpoint: Japan. . |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Patient Surveillance After Cancer Treatment covers the history of cancer patient surveillance after curative-intent treatment, the rationale, the methodologies used in the past and at present, the methodologies that will probably emerge in the future, the costs of surveillance, the definitions of various terms used in the field, and how those who are interested in the topic can get more information about it from the internet. The secondary focus of the book is to publicize the need for well-designed, adequately powered randomized clinical trials comparing two (or more) surveillance strategies for each type of cancer. The audience includes all oncologists, cancer researchers, medical economists and policy makers in government and insurance companies, and finally, interested patients. This book is part of the Current Clinical Oncology series, which provides cutting-edge knowledge of cancer diagnosis, management, and treatment. World renowned experts share their insights in all the major fields of clinical oncology. From the fundamentals of pathophysiology to the latest developments in experimental and novel therapies, Current Clinical Oncology is an indispensable resource for today’s practicing oncologist. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer research. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Radiotherapy. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Surgical oncology. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Oncology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Surgical Oncology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Radiotherapy. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Cancer Research. |
| 655 #7 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| Source of term | local |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Johnson, Frank E. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Maehara, Yoshihiko. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Browman, George P. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Margenthaler, Julie A. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Audisio, Riccardo A. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Thompson, John F. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Johnson, David Y. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Earle, Craig C. |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Virgo, Katherine S. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781603279680 |
| 830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
| Uniform title | Current Clinical Oncology |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="http://ezproxy.alfaisal.edu/login?url=http://dx.doi.org/10.1007/978-1-60327-969-7">http://ezproxy.alfaisal.edu/login?url=http://dx.doi.org/10.1007/978-1-60327-969-7</a> |
| 912 ## - | |
| -- | ZDB-2-SME |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Library of Congress Classification |
| Koha item type | eBooks |
No items available.